Financing co-led by Omega Funds and TCGX, with significant participation from Enavate Sciences and Jeito Capital, alongside Longitude Capital, Blue Owl Healthcare Opportunities, and other leading investment firms Proceeds to advance late-stage AVD-104 program with…
January 09, 2025 08:05 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Prudentia Sciences, an AI-powered technology platform for life sciences announced today its public launch, supported by $7 million in funding. The funding round was led…
December 19, 2024 06:00 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Today, Portal Biotechnologies, Inc. (“Portal”), a cell engineering platform company, announced an oversubscribed $7M seed round led by IA Ventures with participation from Pear VC,…
According to filings with the U.S. Securities and Exchange Commission, Neural Dynamics Technologies is raising up to $5,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have…
Led by Tanglin Venture Partners, the funding round strengthens Ennoventure’s position as a leader in AI-powered brand protection and authentication. CAMBRIDGE, Mass., Nov. 12, 2024 /PRNewswire/ — Ennoventure, Inc., a global leader in AI-powered brand protection and…
The company is working with some of the world’s largest ammonia producers, leveraging its exclusive research collaboration with Schrödinger. November 12, 2024 11:30 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Copernic Catalysts, a developer of novel…
According to filings with the U.S. Securities and Exchange Commission, Vizgen is raising up to $107,575,628.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities…
According to filings with the U.S. Securities and Exchange Commission, Transition Bio is raising up to $21,265,426.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold…
October 16, 2024 04:47 AM Eastern Daylight Time CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, today announced it has completed a USD $75…
– Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI – – Sunbird will use additional funds to further clinical development of validated diagnostic technology across key protein biomarkers in…